PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

UK government launches search for at-home COVID-19 treatments

The UK government has launched a new Antivirals Taskforce in a bid to identify promising home treatments for people who have been exposed to COVID-19.
The new task force will begin the search for novel antiviral medicines that can be taken at home to curb the spread of COVID-19 infection and also speed up recovery time for patients.
The task force will support treatments through clinical trials to enable the rapid roll-out of any promising medicines to patients as early as Autumn.
In addition to identifying novel treatments, the task force will also identify opportunities to manufacture antiviral medicines.
All told, the government is aiming to have at least two effective treatments in its arsenal this year, either in a tablet or capsule form.
The antivirals selected may be used alone or in combination with one another to bolster their effectiveness and reduce the risk of further mutations.
The aim will be for the public to take these medicines at home following a positive COVID-19 test or after exposure to someone who has the virus.
The Antivirals Taskforce will coexist with the government’s existing Therapeutics Taskforce, which will continue to identify and supply effective treatments for all stage of COVID-19 infection and response.
The competition will launch shortly to identify a chair for the new task force, with further details on the leadership structure to be announced in ‘due course’.
“The success of our vaccination programme has demonstrated what the UK can achieve when we bring together our brightest minds,” said Prime Minister Boris Johnson.
“Our new Antivirals Taskforce will seek to develop innovative treatments you can take at home to stop COVID-19 in its tracks. These could provide another vital defence against any future increase in infections and save more lives,” he added.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026